Immune effectors responsible for the elimination of hyperploid cancer cells

References

• Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res. 1970;13:1–27. doi:10.1159/000386035. PMID:4921480.
   PubMed Web of Science ®Google Scholar
• Senovilla L, Galluzzi L, Zitvogel L, Kroemer G. Immunosurveillance as a regulator of tissue homeostasis. Trends Immunol. 2013;34:471–81. doi:10.1016/j.it.2013.06.005. PMID:23891238.
   PubMed Web of Science ®Google Scholar
• Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: From immunosurveillance to tumor escape. Nat Immunol. 2002;3:991–8. doi:10.1038/ni1102-991. PMID:12407406.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144:646–74. doi:10.1016/j.cell.2011.02.013. PMID:21376230.
   PubMed Web of Science ®Google Scholar
• Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: A mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol. 2011;12:385–92. doi:10.1038/nrm3115. PMID:21527953.
   PubMed Web of Science ®Google Scholar
• Olaharski AJ, Sotelo R, Solorza-Luna G, Gonsebatt ME, Guzman P, Mohar A, Eastmond DA. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 2006;27:337–43. doi:10.1093/carcin/bgi218. PMID:16123119.
   PubMed Web of Science ®Google Scholar
• Nguyen HG, Ravid K. Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins. J Cell Physiol. 2006;208:12–22. doi:10.1002/jcp.20565. PMID:16331679.
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature. 2005;437:1043–7. doi:10.1038/nature04217. PMID:16222300.
   PubMed Web of Science ®Google Scholar
• Nguyen HG, Makitalo M, Yang D, Chinnappan D, St Hilaire C, Ravid K. Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. FASEB J. 2009;23:2741–8. doi:10.1096/fj.09-130963. PMID:19332642.
   PubMed Web of Science ®Google Scholar
• Pampalona J, Frias C, Genesca A, Tusell L. Progressive telomere dysfunction causes cytokinesis failure and leads to the accumulation of polyploid cells. PLoS Genet. 2012;8:e1002679. doi:10.1371/journal.pgen.1002679. PMID:22570622.
   PubMed Web of Science ®Google Scholar
• Davoli T, de Lange T. Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell. 2012;21:765–76. doi:10.1016/j.ccr.2012.03.044. PMID:22698402.
   PubMed Web of Science ®Google Scholar
• Castedo M, Senovilla L, Vitale I, Kroemer G. Tetraploid cancer cell precursors in ovarian carcinoma. Cell Cycle. 2012;11:3157–8. doi:10.4161/cc.21722. PMID:22895170.
   PubMed Web of Science ®Google Scholar
• Nicholson JM, Cimini D. Doubling the deck: Tetraploidy induces chromosome shuffling and cancer. Cell Cycle. 2012;11:3354–5. doi:10.4161/cc.21850. PMID:22918235.
   PubMed Web of Science ®Google Scholar
• Davoli T, de Lange T. The causes and consequences of polyploidy in normal development and cancer. Annu Rev Cell Dev Biol. 2011;27:585–610. doi:10.1146/annurev-cellbio-092910-154234. PMID:21801013.
   PubMed Web of Science ®Google Scholar
• Finn OJ. Immuno-oncology: Understanding the function and dysfunction of the immune system in cancer. Ann Oncol. 2012;23( Suppl 8): viii6–9. PMID:22100695.
   PubMedGoogle Scholar
• Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: Reinstating immunosurveillance. Immunity. 2013;39:74–88. doi:10.1016/j.immuni.2013.06.014. PMID:23890065.
   PubMed Web of Science ®Google Scholar
• Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M, et al. An immunosurveillance mechanism controls cancer cell ploidy. Science. 2012;337:1678–84. doi:10.1126/science.1224922. PMID:23019653.
   PubMed Web of Science ®Google Scholar
• Boileve A, Senovilla L, Vitale I, Lissa D, Martins I, Metivier D, van den Brink S, Clevers H, Galluzzi L, Castedo M, et al. Immunosurveillance against tetraploidization-induced colon tumorigenesis. Cell Cycle. 2013;12:473–9. doi:10.4161/cc.23369. PMID:23324343.
   PubMed Web of Science ®Google Scholar
• Bloy N, Garcia P, Laumont CM, Pitt JM, Sistigu A, Stoll G, Yamazaki T, Bonneil E, Buqué A, Humeau J, et al. Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance. Immunol Rev. 2017;280:165–74. doi:10.1111/imr.12582. PMID:29027230.
   PubMed Web of Science ®Google Scholar
• Davoli T, Uno H, Wooten EC, Elledge SJ. Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science. 2017:355. PMID:28126774.
   PubMed Web of Science ®Google Scholar
• Acebes-Huerta A, Lorenzo-Herrero S, Folgueras AR, Huergo-Zapico L, Lopez-Larrea C, Lopez-Soto A, Gonzalez S. Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors. Oncoimmunology. 2016;5:e1074378. doi:10.1080/2162402X.2015.1074378. PMID:27057443.
   PubMed Web of Science ®Google Scholar
• Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD. Adaptive immunity maintains occult cancer in an equilibrium state. Nature. 2007;450:903–7. doi:10.1038/nature06309. PMID:18026089.
   PubMed Web of Science ®Google Scholar
• Wakita D, Chamoto K, Ohkuri T, Narita Y, Ashino S, Sumida K, Nishikawa H, Shiku H, Togashi Y, Kitamura H, et al. IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model. Carcinogenesis. 2009;30:1408–15. doi:10.1093/carcin/bgp144. PMID:19509217.
   PubMed Web of Science ®Google Scholar
• Barrow AD, Edeling MA, Trifonov V, Luo J, Goyal P, Bohl B, Bando JK, Kim AH, Walker J, Andahazy M, et al. Natural killer cells control tumor growth by sensing a growth factor. Cell. 2018;172:534–48 e19. doi:10.1016/j.cell.2017.11.037. PMID:29275861.
   PubMed Web of Science ®Google Scholar
• Lopez-Soto A, Gonzalez S, Lopez-Larrea C, Kroemer G. Immunosurveillance of malignant cells with complex karyotypes. Trends Cell Biol. 2017;27:880–4. doi:10.1016/j.tcb.2017.09.001. PMID:28939156.
   PubMed Web of Science ®Google Scholar
• Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, Dessen P, Zitvogel L, Kroemer G. Apoptosis regulation in tetraploid cancer cells. EMBO J. 2006;25:2584–95. doi:10.1038/sj.emboj.7601127. PMID:16675948.
   PubMed Web of Science ®Google Scholar
• Kalliolias GD, Liossis SN. The future of the IL-1 receptor antagonist anakinra: From rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis. Expert Opin Investig Drugs. 2008;17:349–59. doi:10.1517/13543784.17.3.349. PMID:18321234.
   PubMed Web of Science ®Google Scholar
• Bloy N, Sauvat A, Chaba K, Buque A, Humeau J, Bravo-San Pedro JM, Bui J, Kepp O, Kroemer G, Senovilla L. Morphometric analysis of immunoselection against hyperploid cancer cells. Oncotarget. 2015;6:41204–15. doi:10.18632/oncotarget.5400. PMID:26517677.
   PubMed Web of Science ®Google Scholar
• Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 1992;68:855–67. doi:10.1016/0092-8674(92)90029-C. PMID:1547487.
   PubMed Web of Science ®Google Scholar
• Exley MA, Bigley NJ, Cheng O, Shaulov A, Tahir SM, Carter QL, et al. Innate immune response to encephalomyocarditis virus infection mediated by CD1d. Immunology. 2003;110:519–26. doi:10.1111/j.1365-2567.2003.01779.x. PMID:14632651.
   PubMed Web of Science ®Google Scholar
• Kitamura D, Roes J, Kuhn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 1991;350:423–6. doi:10.1038/350423a0. PMID:1901381.
   PubMed Web of Science ®Google Scholar
• Roopenian DC, Christianson GJ, Sproule TJ, Brown AC, Akilesh S, Jung N, Petkova S, Avanessian L, Choi EY, Shaffer DJ, et al. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol. 2003;170:3528–33. doi:10.4049/jimmunol.170.7.3528. PMID:12646614.
   PubMed Web of Science ®Google Scholar
• Hou B, Reizis B, DeFranco AL. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity. 2008;29:272–82. doi:10.1016/j.immuni.2008.05.016. PMID:18656388.
   PubMed Web of Science ®Google Scholar
• Ikehara S, Pahwa RN, Fernandes G, Hansen CT, Good RA. Functional T cells in athymic nude mice. Proc Natl Acad Sci U S A. 1984;81:886–8. doi:10.1073/pnas.81.3.886. PMID:6608104.
   PubMed Web of Science ®Google Scholar
• Budzynski W, Radzikowski C. Cytotoxic cells in immunodeficient athymic mice. Immunopharmacol Immunotoxicol. 1994;16:319–46. doi:10.3109/08923979409007097. PMID:7528237.
   PubMed Web of Science ®Google Scholar
• McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, Maliszewski CR, Lynch DH, Smith J, Pulendran B, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood. 2000;95:3489–97. PMID:10828034.
   PubMed Web of Science ®Google Scholar
• Bonar SL, Brydges SD, Mueller JL, McGeough MD, Pena C, Chen D, Grimston SK, Hickman-Brecks CL, Ravindran S, McAlinden A, et al. Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PLoS One. 2012;7:e35979. doi:10.1371/journal.pone.0035979. PMID:22558291.
   PubMed Web of Science ®Google Scholar